




Atherosclerosis is a chronic inflammatory disease that results in the build-up of lipid filled 
macrophages, called foam cells, which contribute to the formation of arterial plaque.  
These plaques can obstruct blood flow which can lead to serious complications, such as 
stroke, heart attack, and aneurisms. CXCL5 is a circulating chemokine involved in the 
recruitment of monocytes in acute inflammatory conditions, however, the role that CXCL5 
plays in chronic cardiovascular inflammatory diseases is not defined. Our previous clinical 
studies demonstrated that circulating CXCL5 levels and atherosclerosis severity are 
inversely proportional, suggesting a possible protective role for CXCL5. We hypothesize 
that lower levels of CXCL5 will lead to more severe disease pathology and that CXCL5 
plays an atheroprotective role by altering macrophage metabolism and polarization. To 
investigate the in vivo repercussions of CXCL5 depletion, we challenged wild-type and 
Cxcl5-/- mice with high-fat diet for 16-weeks. Given these mice were not on an atheroprone 
background, as expected, we did not see any evidence of atherosclerosis in isolated 
aortas from mice of either genotype. Surprisingly, the Western diet did not increase 
cholesterol levels to the same extent in Cxcl5-/- mice compared to wild-type mice, however, 
cardiac function was decreased in Cxcl5-/- mice after 16 weeks of the diet. These 
preliminary findings suggest that CXCL5 does play a broad role in the pathophysiological 






Abbreviation Key  
 
Common Abbreviations 
CXCL5 CXC Motif Chemokine Ligand 5 
LDL Low-density Lipoprotein 
HDL High-density Lipoprotein 
ApoE Apolipoprotein E 
 
Blood and Serum Abbreviations 
RBC (M/uL) Red blood cell count.  
HGB (g/dL) Hemoglobin value.  
HCT (%) Hematocrit value: how much of 
total blood count is made up of red 
blood cells.  
MCV (fL) Mean corpuscular volume: 
average size of the red blood cells.  
MCH (pg) Mean corpuscular 
hemoglobin: average amount of 
hemoglobin in red blood cells.  
MCHC (g/dL) Mean corpuscular 
hemoglobin concentration: 
average concentration of hemoglobin in 
red blood cells.  
RDW-SD (fL) Red cell distribution 
width: standard deviation of volume and 
size of red blood cells.  
RDW-CV (%) Red cell distribution 
width: coefficient of variation of volume 
and size of red blood cells.  
RET# (K/uL) Absolute number 
of reticulocytes.  
RET% (%) How much of total blood is 
made of reticulocytes.  
IRF (%) Immature reticulocyte fraction: 
ratio of immature reticulocytes to the 
total number of reticulocytes.  
LFR (%) Low-fluorescence 
reticulocytes: measure of reticulocyte 
maturity, least mature.  
MFR (%) Medium-fluorescence 
reticulocytes: measure of reticulocyte 
maturity, middle maturity.  
HFR (%) High-fluorescence 
reticulocytes: measure of reticulocyte 
maturity, most mature.  
RET-He (pg) Hemoglobin content of 
reticulocytes (used to measure iron 
deficiency).  
PLT (K/uL) Platelet count.  
PDW (fL) Platelet distribution width.  
MPV (fL) Mean platelet volume.  
P-LCR (%) Platelet large cell ratio.  
PCT (%) Plateletcrit: volume occupied 
by platelets in the blood.   
WBC (K/uL) White blood cell count.  
NEUT# (K/uL) Neutrophil count.   
NEUT% (%) Neutrophil ratio.  
LYMPH# (K/uL) Lymphocyte count.  
LYMPH% (%) Lymphocyte ratio.  
MONO# (K/uL) Monocyte count.  
MONO% (%) Monocyte ratio.  
EO# (K/uL) Eosinophil count.  
EO% (%) Eosinophil ratio.  
BASO# (K/uL) Basophil count.  
BASO% (%) Basophil ratio.  
 
Echocardiography Abbreviations  
EF (%) Ejection Fraction 
FS (%) Fractional Shortening  
IVS;d (mm) Interventricular septum 
thickness at end -diastole 
IVS;s (mm) Interventricular septum 
thickness at end -systole 
LV Mass Left ventricle mass 
LV Mass (corrected) Left ventricle 
mass corrected for body weight 
LV Vol;d Left ventricle volume at end -
diastole 
LV Vol;s Left ventricle volume at end -
systole 
LVID;d (mm) Left ventricular internal 
dimension at end -diastole 
LVID;s (mm) Left ventricular internal 
dimension at end -systole 
LVPW;d (mm) Left ventricular posterior 
wall thickness at end -diastole 
LVPW;s (mm) Left ventricular posterior 






Cardiovascular diseases are the leading cause of death in the United States (Heron, 
2018). Atherosclerosis is a chronic inflammatory disease and is the underlying cause of 
many cardiovascular events (Benjamin, 2018). Chronic inflammation plays a large role in 
atherosclerosis, and the recruitment and accumulation of immune cells modulates the 
disease pathology and progression. Macrophages mediate the uptake of native and 
modified LDL. Macrophages have few receptors for native LDL, so they are gathered via 
mainly endocytosis. On the other hand, macrophages have many receptors (scavenger 
receptors) for modified LDL. Therefore, these modified LDL, acetylated LDL (acLDL), 
oxidized LDL (oxLDL), and aggregated LDL (agLDL) are taken up via receptor mediated 
endocytosis. (Schrijvers, 2007). The presence of low-density lipoprotein (LDL) within the 
walls of the arteries trigger activated macrophages to engulf the LDL. When there is 
excessive amounts of LDL present, the amount of lipid engulfed by the macrophages 
becomes toxic, and the cells transition into foam cells. These foam cells are a primary 
component of the necrotic core of the arterial lesion and, therefore, represent potential 
targets in developing therapies for atherosclerosis.  
Chemokines are circulating compounds involved in the recruitment of leukocytes, and are 
thought to be involved throughout the progression of atherosclerosis, making chemokines 
potential therapeutic targets. The ELR+-CXCL chemokine family is known to play a role 
in acute inflammation by activating neutrophils and acting as a chemoattractant, however, 
their role in chronic inflammation is not as clearly defined.  ELR+-CXCL chemokines 
CXCL1 and CXCL2 are induced during the progression of atherosclerosis (Rousselle, 




atherosclerosis lesion progression and foam cell formation remains unknown, however, 
data from our lab suggests that CXCL5 may play a protective role in atherosclerosis due 
to a negative correlation between CXCL5 levels in the blood and coronary artery disease 
(CAD) severity (Ravi, 2017). Additionally, immunoneutralization of CXCL5 in mouse 
models lead to worse atherosclerosis due to an increase in foam cell formation 
(Rousselle, 2013). The inflammatory phenotype of the macrophage (M1 or M2) impacts 
atherosclerosis pathology, and the effect of CXCL5 on macrophage polarization is not 
known. The homeostasis of cholesterol and LDL levels in the blood is maintained by cells 
such as macrophages (Chistiakov, 2017), therefore, CXCL5’s effect on macrophages 
could be influencing the lipid metabolism of these macrophages.  
In this study, mice lacking CXCL5 expression (Cxcl5-/-) and wild-type mice were placed 
on a high-fat, Western diet for 16 weeks. Throughout the study, blood was analyzed for 
both complete cell counts and lipid levels in addition to conscious echocardiography to 
determine the effect of the genotype or diet on cardiac function. Mice are inherently 
resistant to atherosclerosis development, therefore, several preclinical mouse models of 
atherosclerosis have been developed. The atherosclerosis-prone apolipoprotein E-
deficient mouse (ApoE-/-) is a well-established model for studying atherosclerosis (Lo 
Sasso, 2016). We hypothesize is that athero-prone mice deficient in CXCL5 (Cxcl5-/- / 
ApoE-/-) will be more prone to atherosclerosis and generate lesions with higher levels of 
lipid content. However, to establish the Cxcl5-/- animal model in our lab and to identify 
baseline differences in the response to a Western diet, we first studied wild-type and 
Cxcl5-/- mice on a normal, non-athero background (Cxcl5-/-). We hypothesized that we 




/- mice as these mice are not on an atheroprone background. Furthermore, in the absence 
of atherosclerosis, hypothesized that there would not be variation in the blood and serum 
profile or cardiac function between the Cxcl5-/- and wild-type mice. Surprisingly we found 
that Cxcl5-/- mice had altered lipid homeostasis and decreased heart function. 
Materials and Methods     
 
Mice  
C57BL/6 (WT) mice were purchased from by the Jackson Laboratories and the Cxcl5-/- 
mice were established and provided by the Nouailles Lab. The knockout was established 
as described by (Nouailles, 2014) and is a complete knock out. All mice were housed in 
Division of Comparative Medicine (DCM) facilities and handled in accordance to the 
approved protocol (IACUC #17191).   
Table 1. Comparison of Western Diet Chow and Regular Diet Chow.  
Regular Chow Diet  Western Chow Diet  
Measurement  % kcal  % by weight % kcal % by weight 
Protein 24.0 -- 15.2 17.3 
Carbohydrate 60.0 -- 42.7 48.5 
Fat 16.0 -- 42.0 21.2 
Cholesterol -- -- -- 0.2 
     
 
Western Diet Feeding Study 
Mice were started at 8 weeks (+/- 1) on a Western diet for 16 weeks (n ~ 30). The Western 
diet used was TD.88137 Adjusted calories diet (Envigo), which is higher in fat compared 
to the regular chow diet (Table 1). Fasted (8 hr) blood draws occurred via submandibular 
bleed at 0, 8, and 16 weeks, plasma and whole blood was sent to the UNC Animal Clinical 




blood cell type composition. Two-dimensional guided M- mode echocardiography were 
taken using a Vevo 770 ultrasound biomicroscopy system (VisualSonics) in the 
parasternal long-axis view at the level of the papillary muscle. These echocardiographs 
and data acquisition were performed by the MHI Animal Surgery Core Lab. Weight was 
taken every 4 weeks. The aorta and organs (liver, kidneys, brain, gastrocnemius, and 
soleus) were harvested at 16 weeks.     
 
Harvest      
Blood was drawn via submandibular bleed and collected in BD Microtainer Lithium 
Heparin Tubes (REF #365965) BD Microtainer Serum Separator Tubes (REF #365967).  
The mice were then euthanized via CO2, and the aorta identified at the iliac bifurcation 
and extracted up to the aortic arch. In the mice where the en face isolation was performed, 
the liver, brain, kidneys, gastrocnemius and soleus were removed and flash frozen with 
liquid nitrogen and stored at -80°C, and the rest of the organs were discarded. In the mice 
where the cryo isolation was performed, the heart, liver, and brain were fixed in 10% 
neutral buffer formalin overnight, rinsed with PBS twice and stored at 4°C in 70% EtOH, 
and the rest of the organs were discarded.  
En face isolation 
The aorta was perfused with 5 mL of 5 mM EDTA in 1X PBS, 5 mL of ice cold PBS, 5 mL 
of 10% NBF incubate for 5 minutes, then with 10 mL of 5% sucrose in PBS via 25 gauge 
needle into the left ventricle. The aorta was then isolated and put into sucrose formalin (5 
g sucrose in 100 mL of 10%NBF) overnight at 4°C on an agitator. The next day, three 10 




X-100 in PBS (2.5 g Triton X-100 in 500 mL 1X PBS) at Room temp for 1 hr with agitation. 
Three 5 minute PBS washes were repeated and stored at 4°C until ready for staining. 
  
En face staining      
Oil Red-O stock was prepared by adding 0.5mg Oil Red-O powder (Sigma Aldrich,O0625) 
into 100 mL isopropanol. A working solution was made by adding 6.0mL stock to 4.0mL 
diH20 and then filtered through one layer of Whatman paper x 2. The aorta was added to 
60% isopropyl alcohol for 5 min at room temperature and blotted with a KimWipe. The 
aorta was then added to Oil Red-O for 10 min at room temperature and blotted, then 
moved to 60% isopropyl ethanol for 2 min at room temperature and blotted, and finally 
rinsed with dH2O and blotted. Aortas were dipped in hematoxylin for 10 seconds and 
blotted, rinsed with tap water, and stored at 4°C in PBS until imaged.    
Cryo isolation    
The aorta was perfused with 5 mL of 5 mM EDTA in 1X PBS and 5 mL of ice cold PBS 
via 25 guage needle into the left ventricle. A cut was made below the left atrium, 
separating it from the left ventricle and right atrium. The aorta was then isolated and put 
into 10 mL PBS overnight at 4C on an agitator. The next day, aortas were washed three 
times for 10 minute in PBS, and permeabilized in 0.5% Triton X-100 in PBS (2.5g Triton 
X-100 in 500 mL 1X PBS) at room temperature for 1 hr with agitation. The aortas were 
washed three times for 5 minutes, the fat then trimmed off and stored at 4°C until ready 
for processing. Aortas were then cryoprotected in 30% sucrose in 1x PBS until it they 
sunk, then removed. The aortas were then added to OCT (Tissue-Tek, 4583), an 




OCT, snap frozen on dry ice for 3-5 minutes, frozen on ice block for 30 minutes, and 
stored at -80°C.  
 
Peritoneal Macrophage Isolation and Treatment      
Cxcl5-/- and Cxcl5+/+ mice were injected with 2 mL 3% thioglycolate. The peritoneal 
macrophages were harvested 72 hrs post injection. Mice were sacrificed and injected with 
8 mL of ice cold plain RPMI (Gibco, 11875-093) media into the peritoneal cavity via a 
catheter. The cavity was massaged and the media collected. The cells were passed 
through a cell strainer and centrifuged for 5 min at 23°C at 1000 rpm. The supernatant 
was aspirated and the pellet was re-suspended in 10% RPMI (10% Fetal Bovine Serum 
(FBS), 1% Penicillin Streptomycin (pen strep) by volume). 24 hours post isolation, cells 
were washed 3 times with 2.5% RPMI (2.5% FBS and 1% pen strep by volume). 48 hours 
post isolation, CXCL5 test wells were treated with 200 ng/mL CXCL5 chemokine 
(Peprotech 300-22B) in 2.5% RPMI, rest of wells were washed once with 2.5% RPMI. 72 
hours post isolation control wells were washed once with 2.5% RPMI media, CXCL5 wells 
were washed once with 2.5% RPMI media, acetylated Low Density Lipoprotein (acLDL) 
wells were treated with 20 ug/mL acLDL (Alfa Aesar J65029) in 2.5% RPMI, M1 wells 
were treated with 20 ng/mL IFNg (R&D Systems, 285-IF) and 20 ng/mL 
lipopolysaccharides (LPS) (Sigma Aldeich, L4391) in 2.5% RPMI, and M2 wells were 
treated with 20 ng/mL IL4 (R&D Systems, 204-IL-010) and 20 ng/mL IL13 (R&D Systems, 
213-ILB) in 2.5% RPMI. 96 hours post isolation the cells were stained with Oil Red-O. 
 




An Oil Red-O working solution was prepared as described previously. Oil Red-O stock 
was created by adding 0.5mg powder into 100 mL isopropanol. A working solution was 
made by adding 6.0mL stock to 4.0mL diH20 and then filtered through one layer of 
Whatman paper x 2. A fixative solution of 4% formaldehyde was prepared (1.6 mL 37% 
formaldehyde for 13.4 mL PBS). RPMI media was removed from cells and then cells were 
rinsed with PBS. PBS was aspirated and 4% formaldehyde was added for 7 min at room 
temperature then removed. They were washed twice with PBS, then PBS was removed. 
Oil Red-O was added for 4 min at room temperature. The Oil Red-O was removed and 
cells were washed 3 times with PBS and then imaged. 
 
Analysis 
JMP 14 Pro, a statistical analysis software from SAS, was utilized to perform univariate 
split-model ANOVA and multiple comparisons of blood and echocardiography data. 
Univariate analysis was performed on all of the blood and echocardiograph data and the 
p value was determined using a Tukey HSD All Pairwise Comparisons test. All p values 
less than 0.05 were considered significant.  
 
Results 
WT and Cxcl5-/- mice were placed on a high-fat western diet for 16 weeks. Incremental 
blood draws and echocardiographs were performed (Fig. 1). The blood collected was 
analyzed for complete cell counts and lipid profile. The echocardiographs focused on 
heart dimensions and function.  At the end of the feeding study an aorta and organ harvest 





Figure 1. Timeline of feeding study procedures. Mice began the Western Diet at 8 
weeks old, weight was taken every 4 weeks, blood every 8 weeks, and echocardiography 
at the baseline (week 0) and end (week 16).  
 
Figure 2. Aorta isolation and processing. Aortas were collected at the end of the 16 
week Western diet feeding study and processed via either cryo or en face.  
 
Lack of atherosclerosis plaque formation  
Cxcl5-/- and wild-type mice were fed a Western diet for 16 weeks, after which their aortas 
were isolated, processed, and stained. The aortas processed via the en face method did 
not show any atherosclerotic lesions in either genotype (Fig. 3). Mice are inherently 
resistant to atherosclerosis development, therefore, this is expected as neither genotype 




once the ApoE gene is knocked out (Nakashima, 1994), and these studies are currently 
underway.  
 
Figure 3. WT and Cxcl5-/- mice aortas post en face processing. WT and Cxcl5-/- mouse 
aortas were isolated post Western diet, fixed, and stained to determine atherosclerotic 
lesion formation.  
 
The loss of CXCL5 expression results in lower lipid levels in response to Western 
diet 
Plasma obtained from Cxcl5-/- and Cxcl5+/+ mice at 0, 8, and 16 weeks of the Western diet 
was tested for a complete lipid panel and glucose. Glucose and triglyceride levels 
increased in both Cxcl5-/- and Cxcl5+/+ mice in response to the diet, however, there was 
no significant difference between the genotypes (Fig. 4D-E). The lipid levels observed 
were consistent with normal, non-atheroprone mice fed on a Western diet (Hoffler, 2009). 
Since neither genotype was on an athero-prone background, and did not develop (Fig. 








However, surprisingly, we found that Cxcl5-/- mice had significantly lower total cholesterol 
at the end of the 16 week Western diet (Fig. 4A); both HDL and LDL were significantly 
decreased in the Cxcl5-/- mice compared to the wild-type mice (Fig. 4B-C). These data 
suggest that CXCL5 effects lipid homeostasis and that the loss of CXCL5 expression 
leads to lower circulating cholesterol levels when on a Western diet.  
 
Figure 4. Blood Plasma Data From Cxcl5+/+ and Cxcl5-/- Mice. Blood was drawn via 
submandibular bleed from fasted (8 hr) Cxcl5+/+ and Cxcl5-/- mice and was analyzed by 
the UNC Animal Clinical Chemistry Core at week 0, week 8, and week 16. A. Total 
cholesterol levels (mg/dL). B. Low-density lipoprotein levels (mg/dL). C. High-density 
lipoprotein levels (mg/dL). D. Blood glucose levels (mg/dL). E. Triglyceride levels (mg/dL). 
(* - differences between genotypes, † - differences between 8 weeks or 16 weeks to 
baseline weeks, ‡ - differences between 8 weeks and 16 weeks, Variance bar = 90% 
confidence interval and n = approx 30) 
 
Blood Cell Composition 
We measured blood composition at 0, 8, and 16 weeks and looked at the varying levels 
of cell types and the % composition. Among the cell types we investigated were white 
blood cells; white blood cells are the components of the blood that are essential to the 












































































































































blood cells that are capable of differentiating into macrophage and dendritic cells. These 
cells are essential to the immune system response and increased levels and recruitment 
of monocytes are seen in infections and inflammatory diseases.  We saw an increase in 
monocyte count within both Cxcl5-/- and Cxcl5+/+ mice (Fig. 5B). This increase in 
monocytes could be indicative of inflammation occurring within the mice (Shi, 2011). 
Additionally, we saw a decrease in mature reticulocyte (HFR%) within both Cxcl5-/- and 
Cxcl5+/+ mice (Table 2). There were no other significant disparities between the genotypes 
in white blood cell, red blood cell, or platelet composition. (Table 2,3,4).  
 
  
Figure 5. White Blood Cell composition of mice on Western diet. A. White blood cell 
percentage. B. Percentage of white blood cells that are monocytes. (* - differences 
between genotypes, † - differences between 8 weeks or 16 weeks to baseline weeks, ‡ - 
differences between 8 weeks and 16 weeks, Variance bar = 90% confidence interval and 







Table 2. Red Blood Cell Composition Data. Blood was drawn and whole blood and 
plasma isolated at Week 0, Week 8, and Week 16. Results are displayed in the table 
above. (* - differences between genotypes, † - differences between 8 weeks or 16 weeks 
to baseline weeks, ‡ - differences between 8 weeks and 16 weeks, * p < 0.05, ** p < 0.01, 
*** p < 0.001) 
 
Table 3.  White Blood Cell Composition Data. Blood was drawn and whole blood and 
plasma isolated at Week 0, Week 8, and Week 16. Results are displayed in the table 
above. (* - differences between genotypes, † - differences between 8 weeks or 16 weeks 
to baseline weeks, ‡ - differences between 8 weeks and 16 weeks, * p < 0.05, ** p < 0.01, 
*** p < 0.001) 
 
Table 4. Platelet Composition Data. Blood was drawn and whole blood and plasma 
isolated at Week 0, Week 8, and Week 16. Results are displayed in the table above. (* - 
differences between genotypes, † - differences between 8 weeks or 16 weeks to baseline 





Effect of CXCL5 on Heart Function 
Echocardiographs of each mice were performed and data compiled by MHI Animal 
Surgery Core Lab at baseline (week 0) and 16 of the Western diet.  Interestingly, Cxcl5-/- 
mice had lower fractional shortening (FS) and ejection fraction (EF) percentages (Fig. 
6B,D). Fractional shortening and ejection fraction are measures cardiac function (Gao, 
2011). More specifically, the fractional shortening measures ventricle contractility and the 
ejection fraction measures the amount of blood that the left ventricle pumps out after each 
contraction. Additionally, we found that both Cxcl5-/- and Cxcl5+/+ mice experienced an 
increase in left ventricle mass (LV Mass), which could be indicative of hypertrophy due to 
the Western diet (Fig. 6C).  
 
Figure 6. CXCL5 is necessary to maintain cardiac function. Echocardiographs were 
taken at 0 and 16 weeks of the feeding study. A. Sample echocardiograph image from a 
conscious mouse. B. Ejection fraction (%) values. C. Left ventricle mass corrected for 






baseline, * p < 0.05, ** p < 0.01, *** p < 0.001, Variance bar = 90% confidence interval 
and n = approx 30) 
 
CXCL5 does not have an effect on weight gain on mice on a Western diet 
Cxcl5-/- and Cxcl5+/+ mice both gained weight throughout the feeding study, with no 
significant difference in weight by week 16 on the Western diet (Fig. 7).  
 
Figure 7. Weight measurements of Cxcl5+/+ and Cxcl5-/- mice. Weight 
measurements were taken every 4 weeks throughout the feeding study. (* - difference 
between 16 weeks and baseline, † - differences between genotypes, * p < 0.05, ** p < 
0.01, *** p < 0.001, Variance bar = 90% confidence interval and n = approx 30) 
 
Peritoneal Macrophages      
In order to further investigate what affect CXCL5 plays on atherosclerosis progression 
and lipid homeostasis, we looked to macrophages. Peritoneal macrophages were 
harvested, treated with various conditions and stained with Oil Red-O to determine foam 
cell formation. More trials need to be run and lipid uptake will be quantified via FIJI image 
analysis but has not been performed yet; therefore, currently no quantitative analysis can 
be done with this data gathered. However, based on qualitative observations the Cxcl5-/- 
macrophages on seem to have a higher lipid content when compared to the wild-type 





Figure 8. CXCL5 -/- and CXCL5 +/+ Peritoneal Macrophage Staining. Oil Red O stain 
of peritoneal macrophages from Cxcl5-/- and Cxcl5+/+ mouse. The PM were treated with 
the following conditions: 200 ng/mL CXCL5 (CXCL5), 20 ug/mL acLDL (LDL), 20 ng/mL) 





Our data demonstrate that Cxcl5-/- and Cxcl5+/+ mice respond differently to a Western diet. 
Surprisingly, we found that mice lacking CXCL5 had overall lower total cholesterol, HDL, 
and LDL (Fig. 4A-C). Mice lacking CXCL5 also had worsened cardiac function, showing 
lower ejection fraction and fractional shortening values (Fig. 6B, D). Additionally, 
preliminary peritoneal macrophage findings demonstrated that Cxcl5-/- macrophages had 
a higher lipid content (Fig. 8).   
Based on our findings, we hypothesize that CXCL5 acts on the macrophage level to 
reduce atherosclerotic plaques and as well as plays a role in the lipid metabolism. The 
increase in total cholesterol, HDL, and LDL was an unexpected phenotype from the Cxcl5-
/- mice, as we did not expect to see differences between the genotypes (Fig. 4). One 


















































may not have eaten as much of the Western diet, but this is unlikely as the weight gain 
for both genotypes was consistent (Fig. 7). These findings suggest that CXCL5 is having 
an effect on the lipid homeostasis in mice on a Western diet. It should be noted that 
despite the high levels of LDL in the blood at week 16, the WT and Cxcl5-/- mice aortas 
did not show any atherosclerotic plaques (Fig. 3). This pathology is expected to change 
in our future studies using mice that have the apolipoprotein E (ApoE) gene knocked out 
(Nakashima, 1994). Blood composition analysis showed that both WT and Cxcl5-/- mice 
had increased WBC % and monocyte % (Fig. 5). This suggests that both mouse models 
are exhibiting an immune response, possibly due to inflammation (Shi, 2011). Our 
findings also demonstrated that CXCL5 may play a role in cardiac function. Cxcl5-/- mice 
exhibited worsened ejection fraction as well as fractional shortening, suggesting that 
CXCL5 may play a protective role in cardiac function.  
In order to look into the effect of CXCL5 on macrophages in the development of 
atherosclerotic lesions, we looked at macrophages isolated from WT and Cxcl5-/- mice. 
The peritoneal macrophages isolated and treated demonstrated lower lipid levels in 
Cxcl5-/- macrophages. CXCL5 has been shown to upregulate ATP-binding cassette 
transporter 1 (ABCA1), a cholesterol transporter. Deletion of ABCA1 lead to 
hypocholesterolemia in the peripheral blood, while upregulation of ABCA1 lead to 
increased lipid deposits. CXCL5’s upregulation of ABCA1 is thought to lead to a decrease 
in foam cell formation, as ABCA1 allows the cholesterol efflux to be maintained 
(Chistiakov, 2017). This is consistent with the qualitative observation that WT 





To determine how CXCL5 affects the development and progression of atherosclerosis, 
future directions include repeating the feeding study with Cxcl5-/-/ApoE-/- mice. 
Additionally, we will repeat the study with Cxcl5+/+/ApoE-/- mice in order to identify the 
effect that are coming from the ApoE KO. In order to more closely model the clinical cases 
of reduced CXCL5 in patients, we will also repeat the feeding study with Cxcl5+/-/ApoE-/- 
mice. Another experiment includes Cxcl5+/+/ApoE-/- mice on a feeding study with 
implanted mini pumps to measure the effect of excess CXCL5 on atherosclerosis 
progression, to gauge whether additional CXCL5 will play a protective role. Regarding the 
effect of CXCL5 on macrophage polarization and lipid homeostasis, future experiments 
further exploring this concept include treating the M1 and M2 polarized macrophages with 
CXCL5 and LDL in order to measure foam cell formation in the presence of various 
concentrations of CXCL5, as well as looking at the levels of important cholesterol 
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